Literature DB >> 2080048

Is glutamine a conditionally essential amino acid?

J M Lacey1, D W Wilmore.   

Abstract

The nonessential amino acid glutamine has recently been the focus of extensive scientific interest because of its importance in cell and tissue cultures and its physiologic role in animals and humans. Glutamine appears to be a unique amino acid, serving as a preferred respiratory fuel for rapidly proliferating cells, such as enterocytes and lymphocytes; a regulator of acid-base balance through the production of urinary ammonia; a carrier of nitrogen between tissues; and an important precursor of nucleic acids, nucleotides, amino sugars, and proteins. Abundant evidence suggests that glutamine may become a "conditionally essential" amino acid in the critically ill. During stress the body's requirements for glutamine appear to exceed the individual's ability to produce sufficient amounts of this amino acid. Provision of supplemental glutamine in specialized enteral or parenteral feeding may enhance nutritional management and augment recovery of the seriously ill while minimizing hospital stay.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2080048     DOI: 10.1111/j.1753-4887.1990.tb02967.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  116 in total

Review 1.  Enteral nutrition and acute pancreatitis.

Authors:  Q P Chen
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Effects of glutamine on gastrointestinal motor activity in patients following gastric surgery.

Authors:  Erito Mochiki; Tetsuro Ohno; Mitsuhiro Yanai; Yoshitaka Toyomasu; Hiroyuki Andoh; Hiroyuki Kuwano
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

Review 3.  Immunonutrients and neonates.

Authors:  Ying Huang; Xiao Mei Shao; Josef Neu
Journal:  Eur J Pediatr       Date:  2003-01-31       Impact factor: 3.183

4.  Glutamine Supplementation did not Benefit Athletes During Short-Term Weight Reduction.

Authors:  Kevin J Finn; Robin Lund; Mona Rosene-Treadwell
Journal:  J Sports Sci Med       Date:  2003-12-01       Impact factor: 2.988

Review 5.  Glutamine and cancer: cell biology, physiology, and clinical opportunities.

Authors:  Christopher T Hensley; Ajla T Wasti; Ralph J DeBerardinis
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

6.  A randomised, double-blinded, placebo-controlled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients.

Authors:  N M A Blijlevens; J P Donnelly; A H J Naber; A V M B Schattenberg; B E DePauw
Journal:  Support Care Cancer       Date:  2005-03-15       Impact factor: 3.603

Review 7.  Ischemia-reperfusion injury of the intestine and protective strategies against injury.

Authors:  Ismail Hameed Mallick; Wenxuan Yang; Marc C Winslet; Alexander M Seifalian
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

8.  Acute dichloroacetate administration increases skeletal muscle free glutamine concentrations after burn injury.

Authors:  A A Ferrando; D L Chinkes; S E Wolf; S Matin; D N Herndon; R R Wolfe
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

Review 9.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

10.  L-Glutamine and Physical Exercise Prevent Intestinal Inflammation and Oxidative Stress Without Improving Gastric Dysmotility in Rats with Ulcerative Colitis.

Authors:  Raisa de Oliveira Santos; Geovane da Silva Cardoso; Lara da Costa Lima; Mickael Laudrup de Sousa Cavalcante; Mariana Sousa Silva; Ana Karolina Martins Cavalcante; Juliana Soares Severo; Francisca Beatriz de Melo Sousa; Gabriella Pacheco; Even Herlany Pereira Alves; Lívia Maria Soares Nobre; Jand Venes Rolim Medeiros; Roberto Cesar Lima-Junior; Armênio Aguiar Dos Santos; Moisés Tolentino
Journal:  Inflammation       Date:  2020-10-31       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.